June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial
Author Affiliations & Notes
  • Jinhua Bao
    Eye Hospital and School of Ophthalmology and Optometry of Wenzhou Medical University, China
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Yingying Huang
    Eye Hospital and School of Ophthalmology and Optometry of Wenzhou Medical University, China
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • XUE LI
    Eye Hospital and School of Ophthalmology and Optometry of Wenzhou Medical University, China
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Adeline Yang
    R&D AMERA, Essilor International, Singapore
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Ee Woon Lim
    R&D AMERA, Essilor International, Singapore
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Daniel Spiegel
    R&D AMERA, Essilor International, Singapore
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Bjorn Drobe
    R&D AMERA, Essilor International, Singapore
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Hao Chen
    Eye Hospital and School of Ophthalmology and Optometry of Wenzhou Medical University, China
    Wenzhou Medical University–Essilor International Research Center (WEIRC), China
  • Footnotes
    Commercial Relationships   Jinhua Bao, R&D AMERA, Essilor International (F); Yingying Huang, R&D AMERA, Essilor International, (F); XUE LI, R&D AMERA, Essilor International, (F); Adeline Yang, R&D AMERA, Essilor International, (E); Ee Woon Lim, R&D AMERA, Essilor International, (E); Daniel Spiegel, R&D AMERA, Essilor International, (E); Bjorn Drobe, R&D AMERA, Essilor International, (E); Hao Chen, R&D AMERA, Essilor International, (F)
  • Footnotes
    Support  This work was supported by the International S&T Cooperation Program of China (grant no. 2014DFA30940), Wenzhou Medical University Grants 95013006 and 95016010; and was partly supported by collaborative research by Essilor International. IP: WO2019166653 WO2019166654 WO2019166655
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2888. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jinhua Bao, Yingying Huang, XUE LI, Adeline Yang, Ee Woon Lim, Daniel Spiegel, Bjorn Drobe, Hao Chen; Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2888.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the myopia control efficacy of two new designs of spectacle lenses with concentric rings of contiguous aspherical lenslets in a 2-year clinical trial.

Methods : One hundred and seventy Chinese children (aged 8 to 13 years old, myopia between -0.75D and -4.75D) with myopia were randomly assigned to wear one of the three spectacle lenses: spectacle lenses with highly aspherical lenslets (HAL), spectacle lenses with slightly aspherical lenslets (SAL), or control single-vision lenses (SVL) for 2 years. Spherical equivalent of cycloplegic autorefraction (SER) and axial length (AL) were measured on a six-monthly basis. Wearing time was assessed using a questionnaire at each visit.

Results : A total of 157 children completed the 2-year study, of which, 54, 53, and 50 were in the HAL group, SAL group, and SVL group, respectively. After 2 years, the mean SER and AL (± SEM) of the SVL control group increased by -1.46 ± 0.60 D and 0.69 ± 0.26 mm, respectively. Compared with SVL, spectacle lenses with aspherical lenslets significantly slowed myopia progression (HAL, -0.66 ± 0.08 D, difference 0.80 D; SAL, -1.04 ± 0.06 D, difference 0.42 D) and axial elongation (HAL, 0.34 ± 0.03 mm, difference 0.35 mm; SAL, 0.51 ± 0.03 mm, difference 0.18 mm; all p<0.001). In children who wore their lenses every day for at least 12 hours per day, the reduction in SER and AL, compared to SVL group, was greater at 0.99 D (p<0.001) and 0.41 mm (p=0.03) for HAL (n=32) and at 0.57 D (p=0.04) and 0.26 mm (p=0.02) for SAL (n=28), respectively.

Conclusions : Spectacle lenses with aspherical lenslets were effective in slowing myopia progression and axial elongation in children over a two-year period, compared with SVL. Myopia control efficacy was higher in children who wore their lenses full-time (≥12 hours/day) and spectacle lenses with highly aspherical lenslets.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×